Document is current
Any future updates will be listed below
-
Authors
MacMillen, Zachary
Hatzakis, Kiara
Simpson, Adrian
Shears, Melanie J.
Watson, Felicia
Erasmus, Jesse H.
Khandhar, Amit P.
Wilder, Brandon http://orcid.org/0000-0002-5577-7787
Murphy, Sean C. http://orcid.org/0000-0002-2048-0131
Reed, Steven G.
Davie, James W.
Avril, Marion http://orcid.org/0000-0002-3569-2049
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (1R01AI141857, 1R01AI141857, 1R01AI141857, 1R01AI141857)
MalarVx internal funds and partial HDT Bio internal funds.
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
- License Information
-
More Information
Article History
Received: 9 June 2023
Accepted: 12 December 2023
First Online: 10 January 2024
Competing interests
: M.A., Z.M, K.H., J.D. are full-time employees of MalarVx, Inc. M.A. and Z.M. are co-inventors on international patent PCT/US2023/19674. J.D. has equity interests in MalarVx, Inc. A.S., J.H.E., A.P.K. and S.G.R. are full-time employees of HDT Bio. A.S., J.H.E., A.P.K and S.G.R. have equity interests in HDT Bio. J.H.E has consulting agreements with various life sciences companies. J.H.E. and A.P.K. are inventors on granted U.S. patents pertaining to HDT Bio’s proprietary cationic nanocarrier formulation. S. C. M. has a patent application on selected aspects of the prime-and-trap concept through the University of Washington and has equity in a startup company (Sound Vaccines, Inc.) that is negotiating with the University of Washington for rights to this intellectual property. All other authors declare that they have no competing interests.
